TrialPharmacoEconomics1999
An evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing regimens in HIV infection. Canadian perspective.
L Lacey et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it